Follicle Stimulating Hormone (FSH) Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Follicle Stimulating Hormone (FSH) Market:By Product Type (Recombinant Follicle Stimulating Hormone, Urinary follicle Stimulating Hormone), By Application (Assisted Reproductive technology, Infertility Treatment), By End Users (Hospitals, Gynecology Clinics, Infertility Centers) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

The global Follicle Stimulating Hormone (FSH) Market size is expected to reach USD 3.4 billion by 2028, at a CAGR of 4.6% during the forecast period 2022 to 2028. Follicle stimulating hormone (FSH) is a gonadotropic hormone secreted by anterior pituitary gland. It helps in the development of pubertal maturation, and reproductive process. FSH regulates the functions of testes and ovaries. Insufficiency of follicle stimulating hormone may cause the subfertility or infertility in women and men.  However, stringent regulatory guidelines for product approval, alternative procedures for infertility, and lack of awareness in underdeveloped countries may restrain the growth of Follicle Stimulating Hormone (FSH) Market. FSH is a glycoprotein that promotes egg growth in female ovaries and sperm generation in male testes. FSH affects the ovarian follicles directly, prompting them to develop and produce oestrogen. It also causes the Mullerian ducts to regress, triggering gonadal growth, maturation, and steroidogenesis in both sexes by activating particular Leydig cells to generate testosterone or a Mullerian inhibitory chemical. It can also be used in conjunction with human chorionic gonadotropin to induce ultimate oocyte maturation in the clinic (hCG). In addition, a growing number of research utilising animal models such as mice have revealed that LH plays a role in boosting neurological function by enhancing synaptic plasticity and memory. The primary goals of an FSH test in women are to detect abnormalities in menstrual cycles in young females or to suspect the onset of menopause in middle-aged women. FSH tests, like clinical investigative investigations for women, can assist determine a man’s sperm count. As the medical sector undergoes significant transition, it piques healthcare professionals’ interest in clinical trials involving follicles and hormones in people. The commercial exposure of diagnostic treatments and procedures is induced by the use of standard specimens and funding for research projects. The impacts of climate change and the external environment on human health and follicles are also examined in a predicted study.

Follicle Stimulating Hormone (FSH) Market

MARKET SUMMARY
-
4.6% CAGR
  • Study Period– 2022-2028
  • Base Year– 2021
  • CAGR– 4.6%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Follicle Stimulating Hormone (FSH) Market

  • The report on global Follicle Stimulating Hormone (FSH) Market gives historical, current, and future market sizes (US$ Mn) on the basis of product type, application, end user and geography.
  • Follicle Stimulating Hormone (FSH) Market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa
Key Players
  • Merck Serono (Germany)
  • Merck Sharp & Dohme Corp. (Merck & Co. Inc.) (U.S.)
  • Ferring B.V. (Switzerland)
  • IBSA Institut Biochimque SA (Switzerland)
  • Livzon Pharmaceutica Group Inc. (Hong Kong)
Dynamics Follicle Stimulating Hormone Market

Growing incidence of infertility in both men and women due to change in lifestyle, rise in R&D for the synthesis of follicle stimulating hormone (FSH), growing awareness about the follicle stimulating hormones among physicians, and increase in healthcare expenditure are anticipated to fuel the growth of follicle stimulating hormone market over the forecast period.


North-America Got Significant Share

Follicle Stimulating Hormone (FSH) Market

Geographically, global Follicle Stimulating Hormone market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa regions. North America follicle stimulating hormone market is expected to grow at significant rate due to growing awareness about synthetic derivatives among physicians, increase in infertility due to change in lifestyle, and rise R&D for the synthesis of FSH. Europe follicle stimulating hormone market accounted for significant share, which is attributed to adoption of synthetic FSH products, high awareness among the healthcare professionals, and increase in healthcare expenditure. Asia Pacific follicle stimulating hormone market growth driven by presence of large patient pool in India and China and rise in adoption of synthetic FSH. Latin America follicle stimulating hormone market is poised to grow at significant rate due to expansion of business by the companies and economic growth.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market and forecast
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

 

Follicle Stimulating Hormone (FSH) Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The follicle-stimulating hormone (FSH) market is projected to expand at a CAGR of 4.6% during the forecast period

Merck Serono (Germany), Merck Sharp & Dohme Corp. (Merck & Co. Inc.) (U.S.), Ferring B.V. (Switzerland), IBSA Institut Biochimque SA (Switzerland)

North America is the fastest-growing region for the follicle-stimulating hormone (FSH) market

 

 

 

 

 


Report

Table Of Content


Report

Company Profile

  • Merck Serono (Germany)
  • Merck Sharp & Dohme Corp. (Merck & Co. Inc.) (U.S.)
  • Ferring B.V. (Switzerland)
  • IBSA Institut Biochimque SA (Switzerland)
  • Livzon Pharmaceutica Group Inc. (Hong Kong)
  • Techwell Inc. (U.S.)
  • Gedeon Richter Plc (Hungary)
  • GenScience Pharmaceuticals Co. Ltd. (Changchun High & New Tech) (China)

Description

The global Follicle Stimulating Hormone (FSH) Market size is expected to reach USD 3.4 billion by 2028, at a CAGR of 4.6% during the forecast period 2022 to 2028. Follicle stimulating hormone (FSH) is a gonadotropic hormone secreted by anterior pituitary gland. It helps in the development of pubertal maturation, and reproductive process. FSH regulates the functions of testes and ovaries. Insufficiency of follicle stimulating hormone may cause the subfertility or infertility in women and men.  However, stringent regulatory guidelines for product approval, alternative procedures for infertility, and lack of awareness in underdeveloped countries may restrain the growth of Follicle Stimulating Hormone (FSH) Market. FSH is a glycoprotein that promotes egg growth in female ovaries and sperm generation in male testes. FSH affects the ovarian follicles directly, prompting them to develop and produce oestrogen. It also causes the Mullerian ducts to regress, triggering gonadal growth, maturation, and steroidogenesis in both sexes by activating particular Leydig cells to generate testosterone or a Mullerian inhibitory chemical. It can also be used in conjunction with human chorionic gonadotropin to induce ultimate oocyte maturation in the clinic (hCG). In addition, a growing number of research utilising animal models such as mice have revealed that LH plays a role in boosting neurological function by enhancing synaptic plasticity and memory. The primary goals of an FSH test in women are to detect abnormalities in menstrual cycles in young females or to suspect the onset of menopause in middle-aged women. FSH tests, like clinical investigative investigations for women, can assist determine a man’s sperm count. As the medical sector undergoes significant transition, it piques healthcare professionals’ interest in clinical trials involving follicles and hormones in people. The commercial exposure of diagnostic treatments and procedures is induced by the use of standard specimens and funding for research projects. The impacts of climate change and the external environment on human health and follicles are also examined in a predicted study.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX